5-Aminosalicylic Acid in a Slow-Release Preparation: Bioavailability, Plasma Level, and Excretion in Humans
- 1 November 1982
- journal article
- research article
- Published by Elsevier in Gastroenterology
- Vol. 83 (5) , 1062-1070
- https://doi.org/10.1016/s0016-5085(82)80075-9
Abstract
No abstract availableThis publication has 20 references indexed in Scilit:
- Assay of 5-aminosalicylate and its acetylated metabolite in biological fluids by high-performance liquid chromatography on dynamically modified silicaJournal of Chromatography B: Biomedical Sciences and Applications, 1981
- Therapeutic Efficacy of Sulfasalazine and Its Metabolites in Patients with Ulcerative Colitis and Crohn's DiseaseNew England Journal of Medicine, 1980
- Circulating levels of sulphasalazine and its metabolites and their relation to the clinical efficacy of the drug in ulcerative colitis.Gut, 1980
- Effect of sulphapyridine, 5-aminosalicylic acid, and placebo in patients with idiopathic proctitis: a study to determine the active therapeutic moiety of sulphasalazine.Gut, 1980
- Influence of intestinal transit time on azo-reduction of salicylazosulphapyridine (Salazopyrin).Gut, 1979
- The Effect of Sulfasalazine and Its Active Components on Human Polymorphonuclear Leukocyte Function in Relation to Ulcerative ColitisActa Medica Scandinavica, 1979
- AN EXPERIMENT TO DETERMINE THE ACTIVE THERAPEUTIC MOIETY OF SULPHASALAZINEThe Lancet, 1977
- Nephrotoxicity and Molecular StructureXenobiotica, 1975
- The metabolism of salicylazosulphapyridine in ulcerative colitis: I The relationship between metabolites and the response to treatment in inpatientsGut, 1973
- Nephrotoxic Lesions from 5-Aminosalicylic AcidBMJ, 1972